Staphefekt – intervening early in the Colonisation Infection Continuum with endolysins

Staphefekt – intervening early in the Colonisation Infection Continuum with endolysins

With Staphefekt, the first targeted therapy against S. aureus is available for long-term daily maintenance therapy, aimed at decreasing the burden of skin colonisation and preventing progression to inflammation and infection.


Read the article

Share this article

Bekijk een volgend artikel

Prevalence and odds of Staphylococcus aureus carriage in atopic dermatitis: a systematic review and meta-analysis
Prevalence and odds of Staphylococcus aureus carriage in atopic dermatitis: a systematic review and meta-analysis
Staphylococcus aureus and Staphylococcus epidermidis strain diversity underlying pediatric atopic dermatitis
Staphylococcus aureus and Staphylococcus epidermidis strain diversity underlying pediatric atopic dermatitis
Shopping Cart
×

Total-

Subtotal